STRYKER CORP SYK
STRYKER CORP (SYK) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 1.01% (safety: safe). FY2025 revenue was $25.1B at a 12.9% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.62 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-08-03 | Citizens | Market Outperform (main) |
| 2026-07-31 | RBC Capital | Outperform (main) |
| 2026-07-31 | JP Morgan | Overweight (main) |
| 2026-07-31 | Piper Sandler | Overweight (main) |
| 2026-07-31 | Truist Securities | Hold (main) |
| 2026-07-31 | BTIG | Buy (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Forward estimates · earnings calendar →
Consensus analyst estimates and scheduled dates — forward-looking, may change.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.145 |
| Retained earnings / assets | 0.428 |
| EBIT / assets | 0.102 |
| Equity / liabilities | 0.882 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| SYK | STRYKER CORP | 4/9 | 3.96 | 39.3 | +11.2% |
| MMM | 3M CO | 5/9 | 5.46 | 26.3 | +1.5% |
| BDX | BECTON DICKINSON & CO | 6/9 | 2.29 | 25.6 | +8.2% |
| MDLN | Medline Inc. | 6/9 | 2.84 | 44.1 | +11.5% |
| BSX | BOSTON SCIENTIFIC CORP | 4/9 | 2.81 | — | +19.9% |
| BAX | BAXTER INTERNATIONAL INC | 5/9 | 3.86 | — | +5.7% |
| SOLV | Solventum Corp | 6/9 | 2.34 | 8.9 | +0.9% |
About STRYKER CORP
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
FAQ
Is SYK financially healthy?
STRYKER CORP's Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does SYK pay a dividend, and is it safe?
Yes. STRYKER CORP pays a dividend yielding about 1.01% with a 39.6% payout ratio, rated “safe” for safety.
How profitable is SYK?
In FY2025, STRYKER CORP had a net margin of 12.9% and a return on equity of 14.5%.
Is SYK overvalued or undervalued?
STRYKER CORP trades at about 41.3× trailing earnings — near its 10-year norm (10-year range 19.0×–61.3×, median 44.0×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for SYK?
The average Wall-Street price target for STRYKER CORP is $382.04, about 10.0% above the recent price, from 26 analysts (consensus: buy).
Is SYK a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on STRYKER CORP: a Piotroski F-score of 4/9, an Altman Z″ in the safe zone, a P/E of about 39.3×, a dividend yield of 1.01%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.